Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Efavirenz”

295 trials

Showing 20 of 295 results

Large-scale testing (Phase 3)Study completedNCT00013520
What this trial is testing

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,125
Early research (Phase 1)Study completedNCT01867996
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ)

Who this might be right for
Obstetric Labour, Premature
GlaxoSmithKline 18
Large-scale testing (Phase 3)Study completedNCT00000903
What this trial is testing

Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 444
Large-scale testing (Phase 3)Study completedNCT00135382
What this trial is testing

Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen

Who this might be right for
HIV Infections
Bristol-Myers Squibb 254
Testing effectiveness (Phase 2)Study completedNCT00350272
What this trial is testing

Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive Participants

Who this might be right for
HIV Infections
Alexion Pharmaceuticals, Inc. 76
Not applicableStudy completedNCT02249962
What this trial is testing

Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART

Who this might be right for
HIVInfant Exposure to Efavirenz
University of North Carolina, Chapel Hill 12,011
Large-scale testing (Phase 3)Study completedNCT03595709
What this trial is testing

Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (400 mg) in Combo Tablet for Patients Receiving Atripla With Viral Suppression in Taiwan

Who this might be right for
HIV Infections
Yu-Jay Corp. 50
Post-approval studies (Phase 4)UnknownNCT00836212
What this trial is testing

Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring

Who this might be right for
Human Immunodeficiency VirusHIV Infections
University Hospital, Geneva 12
Large-scale testing (Phase 3)Study completedNCT00002448
What this trial is testing

Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 40
Large-scale testing (Phase 3)Study completedNCT00543530
What this trial is testing

Pediatric Expanded Access Program-Oral Solution (0831-908)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC
Post-approval studies (Phase 4)Study completedNCT02529059
What this trial is testing

SSAT058: Atripla to Eviplera Switch in Patients Without Central Nervous System Symptoms

Who this might be right for
HIV
St Stephens Aids Trust 40
Large-scale testing (Phase 3)Study completedNCT01095796
What this trial is testing

Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIVHIV Infections
Gilead Sciences 707
Large-scale testing (Phase 3)Study completedNCT00483054
What this trial is testing

Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin

Who this might be right for
HIV InfectionsTuberculosis
Bamrasnaradura Infectious Diseases Institute 142
Testing effectiveness (Phase 2)Study completedNCT00031070
What this trial is testing

Increasing HAART-Induced Immune Restoration With Cyclosporine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Study completedNCT01695954
What this trial is testing

Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz

Who this might be right for
HyperlipidemiaHIV
NYU Langone Health 34
Large-scale testing (Phase 3)UnknownNCT04022967
What this trial is testing

ANRS 12372 MODERATO Study

Who this might be right for
HIV-1-infection
ANRS, Emerging Infectious Diseases 480
Testing effectiveness (Phase 2)Study completedNCT00364793
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children

Who this might be right for
HIV Infections
Bristol-Myers Squibb 56
Not applicableUnknownNCT01844297
What this trial is testing

Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy

Who this might be right for
AIDS/HIV PROBLEM
Peking Union Medical College 500
Not applicableNo Longer AvailableNCT00162188
What this trial is testing

An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada

Who this might be right for
HIV Infection
Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT00280969
What this trial is testing

Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment

Who this might be right for
HIV Infection
International Medical Center of Japan 71
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation